A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of the study is to further evaluate the PK characteristics of PF-04856883.

Key facts

Study ID

NCT01637285

Run by

Pfizer

People needed

49

Starts

2012-08-01

Expected to finish

2013-01-01

Last updated by the study team

2015-07-31

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• New Haven Clinical Research Unit — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.